Zhejiang Orient Gene Biotech Co.,Ltd. Posted 46.4 Million Yuan Net Loss in First Quarter of 2023

Zhejiang Orient Gene Biotech Co.,Ltd. (浙江东方基因生物制品股份有限公司) (688298.SH) reported a net loss of 46.4 million yuan in the first quarter of 2023, reversing a net profit of 2.1 billion yuan for the same period in the previous year.

Meanwhile, the company posted 376 million yuan in revenue, down 92.1% year-on-year.

At the end of the reporting period, it had 10.5 billion yuan in total assets and 2.3 billion yuan in total liabilities, with a liability-to-asset ratio of 21.6%.